View More Recent Stories

Aug 8, 2024 07:00AM Aldeyra Therapeutics (ALDX) Achieves Primary Endpoint in Phase 3 Dry Eye Disease Clinical Trial of Reproxalap
Aug 8, 2024 06:57AM Aldeyra Therapeutics (ALDX) Halted, News Pending
View More Recent Stories